Bulk Pharmaceutical API Sources for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER

Bulk Pharmaceutical API Sources for THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER

Vendor	Vendor Homepage	Vendor Sku	API Url
Hangzhou APIChem Technology		AC-12160
ABI Chem		AC1L3LQJ
Ambinter		T1505

Bulk Active Pharmaceutical Ingredient (API) Sources for Theophylline 0.4% and Dextrose 5% in Plastic Container

Last updated: August 8, 2025

---

Introduction

The pharmaceutical industry relies heavily on the procurement of high-quality Active Pharmaceutical Ingredients (APIs) to manufacture finished drug products such as solutions, infusions, and syrups. For formulations like Theophylline 0.4% and Dextrose 5% in plastic containers—commonly used in respiratory therapy and nutritional support—the integrity and source of APIs are critical. Identifying reputable API suppliers ensures product safety, efficacy, regulatory compliance, and supply chain resilience.

This article evaluates the current landscape for sourcing bulk APIs—specifically Theophylline and Dextrose—focusing on manufacturers, regional suppliers, quality considerations, and regulatory aspects.

---

Theophylline API Sources

Overview

Theophylline APIs are primarily used to produce bronchodilators administered via nebulizers, inhalers, or oral solutions. The API's quality directly influences therapeutic outcomes, making sourcing from reliable suppliers paramount.

Global Major Suppliers

1. Rotam Pharmaceuticals
   Rotam Pharmaceuticals, a global API manufacturer based in Singapore, supplies pharmaceutical-grade Theophylline. Known for rigorous quality standards conforming to cGMP (current Good Manufacturing Practice), Rotam offers consistent, high-purity Theophylline APIs suitable for infusion and inhalation formulations. Their manufacturing facilities are certified by multiple regulatory authorities, including the US FDA and EMA.

2. Molekula Ltd.
   Based in the UK, Molekula specializes in manufacturing and supplying high-grade APIs, including Theophylline, with a focus on pharmaceutical and nutraceutical applications. They provide APIs with stability and compliance to international pharmacopeias, like USP and EP.

3. Taj Pharmaceuticals
   An Indian manufacturer with an ISO-certified API manufacturing plant, Taj Pharmaceuticals supplies Theophylline APIs globally. Their products meet rigorous quality standards relevant to domestic and international markets, with price competitiveness as a significant advantage.

4. Hubei Huanchi Pharmaceutical Co., Ltd.
   Located in China, this company supplies pharmaceutical-grade Theophylline APIs with a focus on Asia and emerging markets. They hold certifications such as ISO and adhere to Good Manufacturing Practices, ensuring generally acceptable quality standards.

Quality and Regulatory Aspects

API sourcing must align with regulatory directives like the US FDA, EMA, and WHO guidelines. Suppliers with comprehensive quality control systems, stability data, and compliance certificates should be prioritized. Laboratory testing certifications, such as batch-specific Certificates of Analysis (CoA), provide assurance regarding purity (typically >99%), residual solvents, and contaminants.

---

Dextrose 5% API Sources

Overview

Dextrose 5% (D-glucose solution) is commonly used in intravenous infusions, providing caloric supplementation and electrolyte balancing. The source of Dextrose API influences the safety profile of the final product, especially concerning contaminants and endotoxins.

Major Suppliers of Dextrose API

1. Cargill, Inc.
   Cargill is a leading global manufacturer of dextrose APIs, producing pharmaceutical-grade dextrose monohydrate suitable for parenteral solutions. Their APIs conform to USP, EP, and JP standards, with extensive validation protocols and quality documents.

2. Harbin Fine Chemical Co., Ltd.
   A prominent Chinese manufacturer, Harbin supplies Dextrose APIs certified for pharmaceutical use. Their facilities operate under GMP standards, with strict quality control, suitable for injectable and compatible formulations.

3. Colorado Potato Processing Inc. (formerly)
   Though primarily agricultural, some regional suppliers process dextrose from high-grade starch hydrolysis, with pharmaceutical-grade APIs available from certain regional producers.

4. Ingredion Incorporated
   A global ingredient solutions provider, Ingredion supplies dextrose APIs with specifications aligned to pharmacopeial standards, emphasizing purity, low microbial contamination, and endotoxin levels.

Quality and Regulatory Considerations

API suppliers for Dextrose should provide certificates demonstrating compliance with pharmacopeial standards, including limits for microbial contamination, heavy metals, and residual solvents. For injectable solutions, endotoxin testing and sterility assurance are critical.

---

Regional and Specialty API Suppliers

While major global suppliers dominate the market, regional suppliers in India, China, and Southeast Asia are significant due to cost advantages and high-volume manufacturing capacities. However, sourcing from these regions warrants diligent quality verification and supplier audits.

Regulatory Compliance: Suppliers must possess relevant certifications—such as ISO 9001, cGMP, and approvals from local regulatory authorities—and should provide batch-specific documentation for traceability.

Supply Chain Considerations

The stability of supply chains for Theophylline and Dextrose APIs has been challenged recently due to geopolitical issues, pandemic-related disruptions, and logistical bottlenecks. Diversification of suppliers, maintaining strategic stockpiles, and rigorous qualifying of alternate sources are advisable.

---

Conclusion

Identifying reputable suppliers for Theophylline 0.4% and Dextrose 5% APIs involves assessing quality, regulatory compliance, capacity, and supply stability. Major market leaders include Rotam Pharmaceuticals, Molekula, Cargill, and Chinese API manufacturers with verified cGMP standards. Ensuring API purity, consistency, and regulatory adherence minimizes risks associated with contamination, batch variability, and regulatory non-compliance.

---

Key Takeaways

• Prioritize suppliers with established cGMP certification, comprehensive quality control, and regulatory approvals such as USP, EP, or JP compliance.
• For Theophylline, focus on global manufacturers with proven stability data and regulatory track records.
• For Dextrose, source from certified pharmaceutical-grade APIs, with special attention to endotoxin and microbial testing for injectable products.
• Regional suppliers may offer cost advantages but require rigorous qualification protocols.
• Diversify sources to mitigate supply chain risks and ensure uninterrupted production of critical formulations.

---

FAQs

1. What are the primary factors to consider when sourcing APIs for intravenous solutions?
Quality assurance, regulatory compliance, batch consistency, purity, microbiological safety, and supply stability are essential factors.

2. How does API purity impact the safety of Theophylline and Dextrose solutions?
Impurities can lead to adverse reactions, reduce efficacy, or cause contamination-related infections—thus, high purity (typically >99%) and contaminant testing are critical.

3. Are regional API suppliers as reliable as international manufacturers?
While some regional suppliers meet international standards, due diligence—including audits and certification verification—is necessary before qualification.

4. How does regulatory oversight affect API sourcing decisions?
Suppliers with certifications from regulatory authorities like the US FDA, EMA, or GMP-compliant facilities are preferred to ensure compliance and reduce regulatory hurdles.

5. What potential supply chain risks should manufacturers consider?
Geopolitical disruptions, global logistical issues, raw material shortages, and quality variability pose risks that can be mitigated through diversified sourcing and inventory buffers.

---

References

[1] United States Pharmacopeia. USP Monograph on Theophylline.
[2] European Pharmacopoeia. Dextrose Monographs.
[3] Rotam Pharmaceuticals. Corporate Responsibility and Quality Accreditations.
[4] Cargill. Pharmaceutical-grade Dextrose Product Specifications.
[5] WHO Guidelines on the Manufacturing of Injectable Solutions.